New therapies using monoclonal antibodies against lymphocyte signaling pathways might prove helpful in arresting disease progression. sIBM is often misdiagnosed as polymyositis or other diseases ...
Exposures to silica dust, solvents or heavy metals increase the likelihood of developing various forms of myositis, ...
The resemblance of this syndrome to collagen disease has been emphasized in the literature. 29 None of our patients had polymyositis, although the coexistence of Hashimoto's thyroiditis and ...
US biotech Abcuro has reeled in $200 million in third-round financing that should allow it to complete its pivotal trial of ...
The Boston-area company’s previous raises were also aimed at getting its investigational antibody treatment for inclusion ...
Sanofi-backed Abcuro has secured $200 million in series C funds to power its anti-KLRG1 antibody through a phase 2/3 muscle ...
The importance of independent funding for rare diseases like myositis cannot be overstated. Projects increase understanding and gather preliminary data to support applications for larger grants.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback